2 Dirt-Cheap Growth Stocks Trading Near Their 52-Week Lows
Both stocks could turn things around next year.
Source: fool.com
Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Both stocks could turn things around next year.
Both stocks could turn things around next year.
Pfizer is among the companies that will look to deploy capital earned from pandemic treatments and vaccines, analysts believe.
These two big pharma stocks are outstanding value and income vehicles.